No Picture
News

Alopexx Expands Leadership Team with Appointment of Thomas T. Thomas as Chief Financial Officer

CAMBRIDGE, Mass.: CAMBRIDGE, Mass., Oct. 20, 2021 /PRNewswire/ — Alopexx, Inc. a clinical stage biotechnology company focused on developing novel, broad-spectrum immune-mediated therapeutics for the prevention and treatment of bacterial, fungal and parasitic infections, today announced that Thomas T. Thomas has joined the Company as chief financial officer. Mr. Thomas… Click here to view original post… […]

No Picture
News

Manufacturing woes for Novavax’s Covid jab badly disrupt plans for rollout to the poor — report

Production problems at a Novavax facility in Maryland have led to delays in the Covax vaccine sharing program. Now, a shortage of 1 billion doses is expected, as the supplier tries to navigate producing a shot up to regulators’ standards, Politico reported Tuesday. The company has run into trouble with… Click here to view original post… […]

No Picture
News

BeiGene and Nanolek Announce Approval in Russia for BRUKINSA® (Zanubrutinib) for Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma

CAMBRIDGE, Mass. & BEIJING & MOSCOW–(BUSINESS WIRE)—- $BGNE #BGNE–BeiGene and Nanolek announce BRUKINSA® (zanubrutinib) approval in Russia for treatment of patients with relapsed or refractory mantle cell lymphoma. Click here to view original post… […]